Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Avian Influenza Cooperative Research Centers-Studies at the Human-Animal Interface, Request for Applications (RFA) #CI06-009; and Non-Pharmaceutical Interventions for Pandemic Influenza, RFA #CI06-010, 39683 [E6-11018]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 134 / Thursday, July 13, 2006 / Notices
39683
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Centers for Medicare & Medicaid
Services
Designation of a Class of Employees
for Addition to the Special Exposure
Cohort
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Avian
Influenza Cooperative Research
Centers—Studies at the Human-Animal
Interface, Request for Applications
(RFA) #CI06–009; and NonPharmaceutical Interventions for
Pandemic Influenza, RFA #CI06–010
[CMS–4123–N]
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at the Pacific Proving
Grounds, Enewetak Atoll, as an addition
to the Special Exposure Cohort (SEC)
under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. On June 26, 2006,
the Secretary of HHS designated the
following class of employees as an
addition to the SEC:
SUMMARY:
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health, 4676 Columbia
Parkway, MS C–46, Cincinnati, OH
45226, Telephone 513–533–6800 (this is
not a toll-free number). Information
requests can also be submitted by e-mail
to OCAS@CDC.GOV.
Name: ‘‘Avian Influenza Cooperative
Research Centers—Studies at the HumanAnimal Interface,’’ Request for Applications
(RFA) #CI06–009; and ‘‘Non-pharmaceutical
Interventions for Pandemic Influenza,’’ RFA
#CI06–010.
Times and Dates: 8 a.m.–8:30 a.m., August
17, 2006 (Open).
8:30 a.m.–4 p.m., August 17, 2006 (Closed).
8 a.m.–8:30 a.m., August 18, 2006 (Open).
8:30 a.m.–4 p.m., August 18, 2006 (Closed).
Place: Sheraton Gateway Atlanta Airport
Hotel, 1900 Sullivan Road, Atlanta, GA
30337, Telephone Number 770.997.1100.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to RFA #CI06–009, ‘‘Avian
Influenza Cooperative Research Centers—
Studies at the Human-Animal Interface’’; and
RFA #CI06–010, ‘‘Non-pharmaceutical
Interventions for Pandemic Influenza.’’
For Further Information Contact: Felix
Rogers, PhD, M.P.H., Scientific Review
Administrator, National Immunization
Program, CDC, 1600 Clifton Road, NE.,
Mailstop E–05, Atlanta, GA 30333,
Telephone Number 404.639.6101.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 5, 2006.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. E6–11029 Filed 7–12–06; 8:45 am]
Dated: July 6, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–11018 Filed 7–12–06; 8:45 am]
BILLING CODE 4160–17–P
BILLING CODE 4163–18–P
Department of Energy (DOE) employees or
DOE contractor or subcontractor employees
who worked at the Pacific Proving Grounds
(PPG) from 1946 through 1962 for a number
of work days aggregating at least 250 work
days, either solely under this employment or
in combination with work days within the
parameters (excluding aggregate work day
requirements) established for other classes of
employees included in the SEC, and who
were monitored or should have been
monitored.
This designation will become
effective on July 26, 2006, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
sroberts on PROD1PC70 with NOTICES
FOR FURTHER INFORMATION CONTACT:
VerDate Aug<31>2005
17:46 Jul 12, 2006
Jkt 208001
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Medicare Program; Solicitation for
Proposals for Medical Savings
Account Demonstration Project
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice is to inform
interested parties of an opportunity to
apply to participate in the Medicare
Advantage (MA) Medical Savings
Account (MSA) demonstration project.
The MA MSA demonstration design
waives certain MA MSA plan
requirements under sections 1859(b)(3),
1853(e), and 1854(c) of the Social
Security Act. This waiver will allow
entities to offer products that more
closely resemble high deductible health
plans (HDHPs) that are offered with
Health Savings Accounts to the nonMedicare population. This
demonstration will be conducted in
accordance with the Secretary’s
demonstration authority under section
402(a)(1)(A) of the Social Security
Amendments of 1967, 42 U.S.C. 1395b–
1(a)(1)(A).
DATES: Applications will be considered
timely if we receive them by July 21,
2006.
FOR FURTHER INFORMATION CONTACT:
Yolanda Robinson at (410) 786–7627.
Interested parties can obtain a complete
solicitation, application, and supporting
information on the following CMS Web
site at https://www.cms.hhs.gov/
MedicareAdvantageApps/.
ADDRESSES: Mail or deliver applications
and NOIs to the following address:
Centers for Medicare and Medicaid
Services, Attn: Yolanda Robinson CBC/
MAG/DQPM, Mail Stop C4–23–07, 7500
Security Blvd., Baltimore, MD 21244.
Because of staff and resource
limitations, we cannot accept
applications by facsimile (FAX)
transmission or by e-mail.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1851(a)(2)(C) and 1859(b)(3)
of the Social Security Act (the Act)
authorize Medicare Advantage plans to
offer Medical Savings Accounts (MSAs)
to beneficiaries. However, the required
benefit structure is not perceived by
insurance organizations as easily
marketable. Similar to Health Savings
Accounts (HSAs) accounts currently
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 71, Number 134 (Thursday, July 13, 2006)]
[Notices]
[Page 39683]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-11018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panels (SEP): Avian Influenza Cooperative Research Centers--
Studies at the Human-Animal Interface, Request for Applications (RFA)
CI06-009; and Non-Pharmaceutical Interventions for Pandemic
Influenza, RFA CI06-010
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: ``Avian Influenza Cooperative Research Centers--Studies at
the Human-Animal Interface,'' Request for Applications (RFA)
CI06-009; and ``Non-pharmaceutical Interventions for
Pandemic Influenza,'' RFA CI06-010.
Times and Dates: 8 a.m.-8:30 a.m., August 17, 2006 (Open).
8:30 a.m.-4 p.m., August 17, 2006 (Closed).
8 a.m.-8:30 a.m., August 18, 2006 (Open).
8:30 a.m.-4 p.m., August 18, 2006 (Closed).
Place: Sheraton Gateway Atlanta Airport Hotel, 1900 Sullivan
Road, Atlanta, GA 30337, Telephone Number 770.997.1100.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
RFA CI06-009, ``Avian Influenza Cooperative Research
Centers--Studies at the Human-Animal Interface''; and RFA
CI06-010, ``Non-pharmaceutical Interventions for Pandemic
Influenza.''
For Further Information Contact: Felix Rogers, PhD, M.P.H.,
Scientific Review Administrator, National Immunization Program, CDC,
1600 Clifton Road, NE., Mailstop E-05, Atlanta, GA 30333, Telephone
Number 404.639.6101.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 6, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-11018 Filed 7-12-06; 8:45 am]
BILLING CODE 4163-18-P
